Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Vitamin D levels were significantly positively associated with peripheral grey matter volume in patients (β 860.6; 95% confidence interval (CI) 333.4 to 1466, p < .003).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

All participants were genotyped and neuroimaging conducted by structural magnetic resonance imaging.

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D levels, brain volume, and genetic architecture in patients with psychosis

Study design awaiting verification · PLoS ONE · 2018

Original publication title

Vitamin D levels, brain volume, and genetic architecture in patients with psychosis

Akiah Ottesen Berg; Kjetil N. Jørgensen; Mari Nerhus; Lavinia Athanasiu; Alice B. Popejoy; Francesco Bettella; Linn Christin Bonaventure Norbom; Tiril P. Gurholt; Sandra R. Dahl; Ole A. Andreassen; Srdjan Djurovic; Ingrid Agartz; Ingrid Melle

© 2018 Berg et al

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This is the first study of the association between vitamin D levels and brain volume in patients with psychotic disorders that takes into account possible interaction with genetic polymorphisms. The present findings warrant replication in independent samples.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Lower vitamin D levels are found in people with schizophrenia and depressive disorders, and also associated with neuroimaging abnormalities such as reduced brain volume in both animals and humans. Reduced whole brain and increased ventricular volume are also systematically reported in schizophrenia. Even though vitamin D deficiency has been proposed as a risk mechanism for schizophrenia there exist no studies to date of the association between vitamin D levels and brain volume in this population. Therefore, we investigated the relationship between vitamin D levels and brain phenotypes in psychotic disorders, and assessed possible interactions with genetic variants in vitamin D receptor (VDR) and other genetic variants that play a role in vitamin D levels in the body.

Source: Background

Abstract: What methods does the paper describe?

Our sample consisted of 83 psychosis patients and 101 healthy controls. We measured vitamin D levels as serum 25-hydroxyvitamin D. All participants were genotyped and neuroimaging conducted by structural magnetic resonance imaging.

Source: Methods

Abstract: Results

Vitamin D levels were significantly positively associated with peripheral grey matter volume in patients (β 860.6; 95% confidence interval (CI) 333.4 to 1466, p < .003). A significant interaction effect of BSML marker (rs1544410) was observed to mediate the association between patient status and both white matter volume (β 23603.3; 95% CI 2732.8 to 48708.6, p < .05) and whole brain volume (β 46670.6, 95% CI 8817.8 to 93888.3, p < .04). Vitamin D did not predict ventricular volume, which rather was associated with patient status (β 4423.3, 95% CI 1583.2 to 7267.8p < .002) and CYP24A1 marker (rs6013897) (β 2491.5, 95% CI 269.7 to 4978.5, p < .04).

Source: Results

Abstract: Conclusions

This is the first study of the association between vitamin D levels and brain volume in patients with psychotic disorders that takes into account possible interaction with genetic polymorphisms. The present findings warrant replication in independent samples.

Source: Conclusions
Authors’ abstract

Background

Lower vitamin D levels are found in people with schizophrenia and depressive disorders, and also associated with neuroimaging abnormalities such as reduced brain volume in both animals and humans. Reduced whole brain and increased ventricular volume are also systematically reported in schizophrenia. Even though vitamin D deficiency has been proposed as a risk mechanism for schizophrenia there exist no studies to date of the association between vitamin D levels and brain volume in this population. Therefore, we investigated the relationship between vitamin D levels and brain phenotypes in psychotic disorders, and assessed possible interactions with genetic variants in vitamin D receptor (VDR) and other genetic variants that play a role in vitamin D levels in the body.

Methods

Our sample consisted of 83 psychosis patients and 101 healthy controls. We measured vitamin D levels as serum 25-hydroxyvitamin D. All participants were genotyped and neuroimaging conducted by structural magnetic resonance imaging.

Results

Vitamin D levels were significantly positively associated with peripheral grey matter volume in patients (β 860.6; 95% confidence interval (CI) 333.4 to 1466, p < .003). A significant interaction effect of BSML marker (rs1544410) was observed to mediate the association between patient status and both white matter volume (β 23603.3; 95% CI 2732.8 to 48708.6, p < .05) and whole brain volume (β 46670.6, 95% CI 8817.8 to 93888.3, p < .04). Vitamin D did not predict ventricular volume, which rather was associated with patient status (β 4423.3, 95% CI 1583.2 to 7267.8p < .002) and CYP24A1 marker (rs6013897) (β 2491.5, 95% CI 269.7 to 4978.5, p < .04).

Conclusions

This is the first study of the association between vitamin D levels and brain volume in patients with psychotic disorders that takes into account possible interaction with genetic polymorphisms. The present findings warrant replication in independent samples.

Publication and source details

Original title: Vitamin D levels, brain volume, and genetic architecture in patients with psychosis

Akiah Ottesen Berg; Kjetil N. Jørgensen; Mari Nerhus; Lavinia Athanasiu; Alice B. Popejoy; Francesco Bettella; Linn Christin Bonaventure Norbom; Tiril P. Gurholt; Sandra R. Dahl; Ole A. Andreassen; Srdjan Djurovic; Ingrid Agartz; Ingrid Melle

PLoS ONE · 2018

Competing Interests: None of the authors declare a conflict of interest. The submitted work was not carried out in the presence of any personal, professional or financial relationships that could potentially be construed as a conflict of interest.

* E-mail: a.o.berg@medisin.uio.no
© 2018 Berg et al2018Berg et alhttps://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.KG Jebsen Stiftelsen#SKGJ-MED-008The Research Council of Norway#223273The Research Council of Norway#181831The South-Eastern Norway Regional Health Authority#2017-112The South-Eastern Norway Regional Health Authority#2006-258Funding for this study was provided to the Norwegian Centre for Mental Health Research by the KG Jebsen Stiftelsen (Grant #SKGJ-MED-008; http://stiftkgj.no/what-we-do/k-g-jebsen-centres-of-medical-research/?lang=en [link unavailable]), the Research Council of Norway (Grants #223273 and #181831; https://www.forskningsradet.no/en/Home_page/1177315753906) and the South-Eastern Norway Regional Health Authority (Grants #2017-112 and #2006-258; https://www.helse-sorost.no/helsefaglig/forskning). Neither had any role in study design, data collection, analysis and interpretation, writing of the report, or the decision to submit the paper for publication.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:11:54.012087+00:00

DOI: 10.1371/journal.pone.0200250 · PMC6108467